ETPN management

After decision of the General Assembly 2017 in Torremolinos – Malaga (Spain), please find below the current composition of the ETPN Executive Board

Last updated: 30.10.2017

 ETPN Bureau

Patrick Boisseau

Patrick Boisseau

ETPN Chairman

VP HealthTech at CEA Leti, France

Didier Letourneur

Didier Letourneur

ETPN Vice-Chairperson

Director of Research – DR CNRS – INSERM U1148

Laurent Levy

Laurent Levy

ETPN Vice-Chairperson

CEO Nanobiotix, France

Philippe Mauberna

Philippe Mauberna

ETPN Treasurer

CFO at Nanobiotix

ETPN Working group leaders

Eusebio Gainza

Eusebio Gainza

W.G. Nanotherapeutics and targeted delivery

R&D Manager, BIOPRAXIS RESEARCH, Spain

Furio Gramatica

Furio Gramatica

W.G. Clinical interface

Director, Development and Innovation at Fondazione Don Carlo Gnocchi

Olaf Rothaus

Olaf Rothaus

Chair of the Mirror Group

EuroNanoMed – Network Steering Commitee Chair, VDI Technologiezentrum GmbH, Germany

Paul Galvin

Paul Galvin

W.G. Medical devices

Head of ICT for Health Programmes at Tyndall National Institute

Adriele Prina-Mello

Adriele Prina-Mello

W.G. Education & Training

NANOMEDICINE PI at Trinity College Dublin, Ireland

Hans-Jörg Meisel

Hans-Jörg Meisel

W.G. Regenerative Medicine

Director Center of Neurosciences, BG-Clinic Bergmannstrost Halle

Pedro Silva

Pedro Silva

W.G. Business Opporttunities

Technology Transfer Director at Instituto de Medicina Molecular, Lisbon

Klaus-Michael Weltring

Klaus-Michael Weltring

A.G. Ethics & Social impact of Nanomedicine

Managing Director, Bioanalytik Muenster, Germany

Andreas Falk

Andreas Falk

W.G. Safety & characterization

CEO at BioNanoNet Forschungsgesellschaft mbH, Austria

ETPN Secretariat operational team

Alexandre Ceccaldi

Alexandre Ceccaldi

ETPN General Secretary

Coordinator of the NOBEL Project

Alexandre Superville

Alexandre Superville

Assistant manager of the NOBEL H2020 Project